Boiron SA (BOIRF)

Market Cap	580.23M +22.9%
Revenue (ttm)	588.36M +2.8%
Net Income	38.33M +188.0%
EPS	2.21 +188.0%
Shares Out	n/a
PE Ratio	15.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Open	31.90
Previous Close	30.00
Day's Range	31.90 - 31.90
52-Week Range	24.00 - 32.28
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 17, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,634
• Stock Exchange: OTCMKTS
• Ticker Symbol: BOIRF

Financial Performance

In 2025, Boiron's revenue was 501.11 million, an increase of 2.78% compared to the previous year's 487.56 million. Earnings were 32.64 million, an increase of 187.96%.

Financial numbers in EUR